BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15843377)

  • 1. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
    Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
    J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.
    Mayo LD; Dixon JE; Durden DL; Tonks NK; Donner DB
    J Biol Chem; 2002 Feb; 277(7):5484-9. PubMed ID: 11729185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Findley HW; Jiang R; Woods WG
    Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.
    Mayo LD; Donner DB
    Trends Biochem Sci; 2002 Sep; 27(9):462-7. PubMed ID: 12217521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
    Knights CD; Liu Y; Appella E; Kulesz-Martin M
    J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms.
    Freeman DJ; Li AG; Wei G; Li HH; Kertesz N; Lesche R; Whale AD; Martinez-Diaz H; Rozengurt N; Cardiff RD; Liu X; Wu H
    Cancer Cell; 2003 Feb; 3(2):117-30. PubMed ID: 12620407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2.
    Lee SJ; Lim CJ; Min JK; Lee JK; Kim YM; Lee JY; Won MH; Kwon YG
    Cell Death Differ; 2007 Jun; 14(6):1106-16. PubMed ID: 17318220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
    Arriola EL; Lopez AR; Chresta CM
    Oncogene; 1999 Jan; 18(4):1081-91. PubMed ID: 10023685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of p53 stability and function in HCT116 colon cancer cells.
    Kaeser MD; Pebernard S; Iggo RD
    J Biol Chem; 2004 Feb; 279(9):7598-605. PubMed ID: 14665630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
    Kulikov R; Boehme KA; Blattner C
    Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN regulates Mdm2 expression through the P1 promoter.
    Chang CJ; Freeman DJ; Wu H
    J Biol Chem; 2004 Jul; 279(28):29841-8. PubMed ID: 15090541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 mediated nuclear exclusion of p53 attenuates etoposide-induced apoptosis in neuroblastoma cells.
    Rodriguez-Lopez AM; Xenaki D; Eden TO; Hickman JA; Chresta CM
    Mol Pharmacol; 2001 Jan; 59(1):135-43. PubMed ID: 11125034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of PTEN transcription by p53.
    Stambolic V; MacPherson D; Sas D; Lin Y; Snow B; Jang Y; Benchimol S; Mak TW
    Mol Cell; 2001 Aug; 8(2):317-25. PubMed ID: 11545734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt enhances Mdm2-mediated ubiquitination and degradation of p53.
    Ogawara Y; Kishishita S; Obata T; Isazawa Y; Suzuki T; Tanaka K; Masuyama N; Gotoh Y
    J Biol Chem; 2002 Jun; 277(24):21843-50. PubMed ID: 11923280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis.
    Townsend PA; Scarabelli TM; Davidson SM; Knight RA; Latchman DS; Stephanou A
    J Biol Chem; 2004 Feb; 279(7):5811-20. PubMed ID: 14602726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of p53 on key serines is dispensable for transcriptional activation and apoptosis.
    Thompson T; Tovar C; Yang H; Carvajal D; Vu BT; Xu Q; Wahl GM; Heimbrook DC; Vassilev LT
    J Biol Chem; 2004 Dec; 279(51):53015-22. PubMed ID: 15471885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.
    Mayo LD; Donner DB
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11598-603. PubMed ID: 11504915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.